-
1Academic Journal
Source: Scientific and practical specialized journal "Rheumatology of Kazakhstan". :36-44
Subject Terms: antirheumatic drugs, antimalarial drugs, COVID-19, противомалярийные препараты, 3. Good health, противоревматичекие препараты
-
2Academic Journal
Authors: Dryakhlova, L. A., Salamatova, S. A., Bakurinskikh, A. A., Gaisyna, E. F., Дряхлова, Л. А., Саламатова, С. А., Бакуринских, А. А., Гайсина, Е. Ф.
Source: Сборник статей
Subject Terms: MALARIA, PREGNANCY, ANTIMALARIAL DRUGS, SAFETY, TREATMENT, МАЛЯРИЯ, БЕРЕМЕННОСТЬ, ПРОТИВОМАЛЯРИЙНЫЕ ПРЕПАРАТЫ, БЕЗОПАСНОСТЬ, ЛЕЧЕНИЕ
File Description: application/pdf
Relation: Актуальные вопросы современной медицинской науки и здравоохранения: Материалы VI Международной научно-практической конференции молодых учёных и студентов, посвященной году науки и технологий, (Екатеринбург, 8-9 апреля 2021): в 3-х т.; http://elib.usma.ru/handle/usma/5969
Availability: http://elib.usma.ru/handle/usma/5969
-
3Academic Journal
Source: Безопасность и риск фармакотерапии, Vol 5, Iss 3, Pp 112-116 (2018)
Subject Terms: малярия, противомалярийные препараты, производные артемизинина, malaria, antimalarial drugs, artemisinin derivatives, Therapeutics. Pharmacology, RM1-950
File Description: electronic resource
-
4Academic Journal
Authors: O. D. Ostroumova, E. Yu. Shahova, A. I. Kochetkov, О. Д. Остроумова, Е. Ю. Шахова, А. И. Кочетков
Contributors: The study was performed without external funding., Работа выполнена без спонсорской поддержки.
Source: Safety and Risk of Pharmacotherapy; Том 7, № 4 (2019); 176-189 ; Безопасность и риск фармакотерапии; Том 7, № 4 (2019); 176-189 ; 2619-1164 ; 2312-7821 ; 10.30895/2312-7821-2019-7-4
Subject Terms: нестероидные противовоспалительные препараты, drug-induced eosinophilia, аdverse drug reaction, antibiotics, sulfanilamides, antimalarial drugs, anti-seizure medications, nonsteroidal anti-inflammatory drugs, лекарственно-индуцированная эозинофилия, нежелательные побочные реакции, антибиотики, сульфаниламиды, противомалярийные препараты, противосудорожные препараты
File Description: application/pdf
Relation: https://www.risksafety.ru/jour/article/view/156/203; Berkow R, Fletcher AJ, eds. The Merck manual of diagnosis and therapy. 16th ed. Rahway: Merck Research Laboratories; 1992.; Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine. 3rd ed. Oxford: Oxford University Press; 1995.; Maidment I, Williams C. Drug-induced eosinophilia. Pharm J. 2000;264(7078):71–6.; Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68(3):301–8. https://doi.org/10.1016/j.alit.2019.03.006; Watanabe H. Recent advances in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. J Immunol Res. 2018;2018:5163129. https://doi.org/10.1155/2018/5163129; Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012;49(2):149–59. https://doi.org/10.1053/j.seminhematol.2012.01.006; Blumenthal KG, Youngster I, Rabideau DJ, Parker RA, Manning KS, Walensky RP, Nelson SB. Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics. J Allergy Clin Immunol. 2015;136(5):1288–94.e1. https://doi.org/10.1016/j.jaci.2015.04.005; Rauscher C, Freeman A. Drug-induced eosinophilia. Allergy Asthma Proc. 2018;39(3):252–6. https://doi.org/10.2500/aap.2018.39.4120; Lopez M, Salvaggio JE. Eosinophilic pneumonias. Immunol Allergy Clin North Am. 1992;12(2):349–63.; Jessop JD, Dippy J, Turnbull A, Bright M. Eosinophilia during gold therapy. Rheumatology. 1974;13(2):75–80. https://doi.org/10.1093/rheumatology/13.2.75; Edelman J, Davis P, Owen ET. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis. J Rheumatol. 1983;10(1):121–3.; Савочкина ДИ. DRESS-синдром (DIHS-синдром): этиология, патогенез, симптомы. Международный студенческий научный вестник. 2018;(4):298–300.; Воржева ИИ, Черняк БА. Поражения легких при системной реакции лекарственной гиперчувствительности с эозинофилией: обзор литературы и клинические наблюдения. Практическая пульмонология. 2018;(2):59–68.; Moshari J, Niazkar HR, Shahri MK, Ghorbani M, Darafshi R. Drug-induced eosinophilia secondary to the cotrimoxazole administration in acute brucellosis. Asian J Pharm Clin Res. 2018;11(9):3–4. http://dx.doi.org/10.22159/ajpcr.2018.v11i9.25610; Morrisroe K, Wong M. Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis. Rheumatology. 2015;54(11):2113–4. https://doi.org/10.1093/rheumatology/kev275; Broccolo F, Ciccarese G, Picciotto A, Drago F. A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection. J Hepatol. 2015;62(1):248–9. https://doi.org/10.1016/j.jhep.2014.09.014; Демко ИВ, Собко EA, Ищенко ОП, Соловьева ИА, Крапошина АЮ, Аристархова ЛВ и др. DIHS/DRESS синдром, вызванный карбамазепином. Лечение и профилактика. 2016;3(19):56–9.; Шаленкова МА, Михайлова ЗД. Эозинофилия как осложнение длительного приема кордарона. Медицинский альманах. 2009;(1):215–8.; Kowalszki A, Sheikh J, Weller PF. Eosinophils and eosinophilia. In: Rich RR, ed. Clinical immunology: principles and practice. 4th ed. London: Elsevier Saunders; 2013. P. 298–309.; Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139(8):683–93. https://doi.org/10.7326/0003-4819-139-8-200310210-00012; Wykoff R. Eosinophilia. Southern Med J. 1986;79(5):608–12. https://doi.org/10.1097/00007611-198605000-00021; Spry CJF. Eosinophilia and allergic reactions to drugs. Clin Haematol. 1980;9(3):521–34.; Girard JP, Kunz ML, Kobayashi S, Rose NR, Arbesman CE. Penicillin hypersensitivity with eosinophilia: a case report with immunologic studies. Am J Med. 1967;42(3):441–8. https://doi.org/10.1016/0002-9343(67)90272-0; Romano A, Di Fonso M, Pocobelli D, Giannarini L, Venuti A, Garcovich A. Two cases of toxic epidermal necrolysis caused by delayed hypersensitivity to beta-lactam antibiotics. J Investig Allergol Clin Immunol. 1993;3(1):53–5.; Fenoglio JJ Jr, McAllister HA Jr, Mullick FG. Drug related myocarditis: I. Hypersensitivity myocarditis. Hum Pathol. 1981;12(10):900–7. https://doi.org/10.1016/s0046-8177(81)80195-5; Felman RH, Sutherland DB, Conklin JL, Mitros FA. Eosinophilic cholecystitis, appendiceal inflammation, pericarditis, and cephalosporin-associated eosinophilia. Dig Dis Sci. 1994;39(2):418–22. https://doi.org/10.1007/bf02090217; Verma S, Kieff E. Cephalexin-related nephropathy. JAMA. 1975;234(6):618–9. https://doi.org/10.1001/jama.1975.03260190046023; Smith JH, Weinstein VF. Cephalexin associated pulmonary infiltration with circulating eosinophilia. Br Med J (Clin Res Ed). 1987;294(6574):776. https://doi.org/10.1136/bmj.294.6574.776-d; Marik PE, Ferris N. Delayed hypersensitivity reaction to vancomycin. Pharmacotherapy. 1997;17(6):1341–4.; Hannah B, Kimmel P, Dosa S, Turner M. Vancomycin-induced toxic epidermal necrolysis. South Med J. 1990;83(6):720–2. https://doi.org/10.1097/00007611-199006000-00035; Frye RF, Job ML, Dretler RH, Rosenbaum BJ. Teicoplanin nephrotoxicity: first case report. Pharmacotherapy. 1992;12(3):240–2.; Shaughnessy KK, Bouchard SM, Mohr MR, Herre JM, Salkey KS. Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis. J Am Acad Dermatol. 2010;62(2):315–8. https://doi.org/10.1016/j.jaad.2009.05.046; Sitbon O, Bidel N, Dussopt C, Azarian R, Braud ML, Lebargy F, et al. Minocycline pneumonitis and eosinophilia. A report on eight patients. Arch Intern Med. 1994;154(14):1633–40. https://doi.org/10.1001/archinte.1994.00420140105013; Parneix-Spake A, Bastuji-Garin S, Lobut JB, Erner J, Guyet-Rousset P, Revuz J, Roujeau JC. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol. 1995;131(4):490–1. https://doi.org/10.1001/archderm.1995.01690160120024; Maubec E, Wolkenstein P, Loriot MA, Wechsler J, Mulot C, Beaune P, et al. Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology. 2008;216(3):200–4. https://doi.org/10.1159/000112926; Ho D, Tashkin DP, Bein ME, Sharma O. Pulmonary infiltrates with eosinophilia associated with tetracycline. Chest. 1979;76(1):33–6. https://doi.org/10.1378/chest.76.1.33; Lorber B, Cutler C, Barry WE. Allergic rash due to amphotericin B. Ann Intern Med. 1976;84(1):54. https://doi.org/10.7326/0003-4819-84-1-54; Asperilla MO, Smego RA Jr. Eosinophilic meningitis associated with ciprofloxacin. Am J Med. 1989;87(5):589–90. https://doi.org/10.1016/S0002-9343(89)80620-5; Feinmann L. Drug-induced lung disease: pulmonary eosinophilia and sulphonamides. Proc R Soc Med. 1975;68(7):440–1.; Sovijärvi ARA, Lemola M, Stenius B, Idänpään-Heikkilä J. Nitrofurantoin induced acute, subacute and chronic pulmonary reactions. A report of 66 cases. Scand J Resp Dis. 1977;58(1):41–50.; Davidson AC, Bateman C, Shovlin C, Marrinan M, Burton GH, Cameron IR. Pulmonary toxicity of malaria prophylaxis. BMJ. 1989;297(6658):1240–1. https://doi.org/10.1136/bmj.297.6658.1240; Janier M, Guillevin L, Badillet G. Pulmonary eosinophilia associated with dapsone. Lancet. 1994;343(8901):860–1. https://doi.org/10.1016/S0140-6736(94)92066-4; Wong PC, Yew WW, Wong CF, Choi HY. Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement. Eur Respir J. 1995;8(5):866–8.; Lee M, Berger HW. Eosinophilia caused by rifampin. Chest. 1980;77(4):579. https://doi.org/10.1378/chest.77.4.579b; Lange P, Oun H, Fuller S, Turney JH. Eosinophilic colitis due to rifampicin. Lancet. 1994;344(8932):1296–7.https://doi.org/10.1016/S0140-6736(94)90782-X; Zhang SN, He QX, Yang NB, Ni SL, Lu MQ. Isoniazid-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Presenting as acute eosinophilic myocarditis. Intern Med. 2015;54(10):1227–30. https://doi.org/10.2169/internalmedicine.54.3511.; Kayanakis JG, Giraud P, Fauvel JM, Bounhoure JP. Eosinophilia during captopril treatment. Lancet. 1980;316(8200):923. https://doi.org/10.1016/S0140-6736(80)92085-1; Watanabe K, Nishimura K, Shiode M, Sekiya M, Ikeda S, Inoue Y, Iwanaga C. Captopril, an angiotensin-converting enzyme inhibitor, induced pulmonary infiltration with eosinophilia. Intern Med. 1996;35(2):142–5. https://doi.org/10.2169/internalmedicine.35.142; Barnes JN, Davies ES, Gent CB. Rash, eosinophilia and hyperkalaemia associated with enalapril. Lancet. 1983;322(8340):41–2. https://doi.org/10.1016/S0140-6736(83)90020-X; Benard A, Melloni B, Gosselin B, Bonnaud F, Wallaert B. Perindopril-associated pneumonitis. Eur Respir J. 1996;9(6):1314–6. https://doi.org/10.1183/09031936.96.09061314; Wathen CG, MacDonald T, Wise LA, Boyd SM. Eosinophilia associated with spironolactone. Lancet. 1986;1(8486):919–20. https://doi.org/10.1016/s0140-6736(86)91026-3; Dominguez EA, Hamill RJ. Drug-induced fever due to diltiazem. Arch Intern Med. 1991;151(9):1869–70. https://doi.org/10.1001/archinte.1991.00400090141026; Dukes MNG. Meylers side effects of drugs. 13th ed. Oxford: Elsevier Press; 1996.; Marcos Sánchez F, Aparicio Martínez JC, Durán Pérez-Navarro A. Eosinophilia caused by low-molecular-weight heparin. An Med Interna. 1992;9(5):256.; Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc. 1985;60(7):463–8. https://doi.org/10.1016/S0025-6196(12)60870-2; Bacon HM. Eosinophilia associated with chlorpromazine therapy. Am J Psychiatry. 1964;120(9):915–6. https://doi.org/10.1176/ajp.120.9.915; Shear MK. Chlorpromazine-induced PIE syndrome. Am J Psychiatry. 1978;135(4):492–3. https://doi.org/10.1176/ajp.135.4.492; Keshaven MS, Kennedy JS, eds. Adverse hematological effects in drug-induced dysfunction in psychiatry. New York: Hemisphere Publishing Corporation; 1992.; Amsterdam JD. Loeffler’s syndrome: an uncommon adverse reaction to imipramine. Int Clin Psychopharmacol. 1986;1(3):260–2.; Salerno SM, Strong JS, Roth BJ, Sakata V. Eosinophilic pneumonia and respiratory failure associated with a trazodone overdose. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2170–2. https://doi.org/10.1164/ajrccm.152.6.8520792; Anderson BN, Henrikson IR. Jaundice and eosinophilia associated with amitriptyline. J Clin Psychiatry. 1978;39(9):730–1.; Hartzema AG, Porta MS, Tilson HH, Milburn DS, Myers CW. Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome. DICP. 1991;25(11):1259–62. https://doi.org/10.1177%2F106002809102501116; CSM/MCA. L-Tryptophan (Optimax): limited availability for resistant depression. Current Problems in Pharmacovigilance. 1994;20:2.; Kaufman LD, Gruber BL, Gregersen PK. Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome. Lancet. 1991;337(8749):1071–4. https://doi.org/10.1016/0140-6736(91)91717-9; Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM. Eosinophilia-myalgia syndrome: results of national surveillance. JAMA. 1990;264(13):1698–703. https://doi.org/10.1001/jama.1990.03450130070029; Weber RW. Adverse drug effects and the spectrum of eosinophilic pulmonary disorders. Ann Allergy Asthma Immunol. 1995;74(6):451–3.; Salzman MB, Valderrama E, Sood SK. Carbamazepine and fatal eosinophilic myocarditis. N Engl J Med. 1997;336(12):878–9. https://doi.org/10.1056/NEJM199703203361216; Mahatma M, Haponik EF, Nelson S, Lopez A, Summer WR. Phenytoin-induced acute respiratory failure with pulmonary eosinophilia. Am J Med. 1989;87(1):93–4. https://doi.org/10.1016/S0002-9343(89)80490-5; Lazoglu AH, Boglioli LR, Dorsett B, Macris NT. Phenytoin-related immunodeficiency associated with Loеffler’s syndrome. Ann Allergy Asthma Immunol. 1995;74(6):479–82.; Kaufman J, O’Shaughnessy I. Eosinophilic pleural effusion associated with valproic acid administration. South Med J. 1995;88(8):881–2. http://dx.doi.org/10.1097/00007611-199508000-00023; Rich MW, Thomas RA. A case of eosinophilic pneumonia and vasculitis induced by diflunisal. Chest. 1997;111(6):1767–9. https://doi.org/10.1378/chest.111.6.1767; Goodwin SD, Glenny RW. Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia: review of the literature and Food and Drug Administration Adverse Drug Reaction reports. Arch Intern Med. 1992;152(7):1521–4. https://doi.org/10.1001/archinte.1992.00400190139026; Khalil H, Molinary E, Stoller JK. Diclofenac (Voltaren)-induced eosinophilic pneumonitis: case report and review of the literature. Arch Intern Med. 1993;153(14):1649–52. https://doi.org/10.1001/archinte.1993.00410140031004; Quinn JP, Weinstein RA, Caplan LR. Eosinophilic meningitis and ibuprofen therapy. Neurology. 1984;34(1):108. https://doi.org/10.1212/WNL.34.1.108; Edelman J, Mastaglia GL, Owen ET. The clinical significance of eosinophilia during gold salt therapy in rheumatoid arthritis. Aust N Z J Med.1981;11:723.; Cooke N, Bamji A. Gold lung. Rheumatology. 1981;20(3):129–35. https://doi.org/10.1093/rheumatology/20.3.129; Andreu V, Bataller R, Caballería J, Rodés J. Acute eosinophilic pneumonia associated with ranitidine. J Clin Gastroenterol. 1996;23(2):160–2.https://doi.org/10.1097/00004836-199609000-00023; Gafter U, Komlos L, Weinstein T, Zevin D, Levi J. Thrombocytopenia, eosinophilia, and ranitidine. Ann Intern Med. 1987;106(3):477. https://doi.org/10.7326/0003-4819-106-3-477_1; Tishler M, Abramov AL. Cimetidine-induced eosinophilia. Drug Intell Clin Pharm. 1985;19(5):377–8. https://doi.org/10.1177%2F106002808501900510; Smith JD, Chang KL, Gums JG. Possible lansoprazole-induced eosinophilic syndrome. Ann Pharmacother. 1998;32(2):196–200. https://doi.org/10.1345/aph.17190; D’adamo G, Spinelli C, Forte F, Gangeri F. Omeprazole-induced acute interstitial nephritis. Ren Fail. 1997;19(1):171–5. https://doi.org/10.3109/08860229709026272; Timmer R, Duurkens VA, Van Hees PA. Sulphasalazine-induced eosinophilic pneumonia. Neth J Med. 1992;41(3–4):153–7.; Bitton A, Peppercorn MA, Hanrahan JP, Upton MP. Mesalamine-induced lung toxicity. Am J Gastroenterol. 1996;91(5):1039–40.; Bell RJM. Pulmonary infiltration with eosinophils caused by chlorpropamide. Lancet. 1964;283(7345):1249–50. https://doi.org/10.1016/S0140-6736(64)91872-0; Diffee JJ 3rd, Hayes JM, Montesi SA, Greene WL, Milnor PJr. Chlorpropamide-induced pulmonary infiltration and eosinophilia with multisystem toxicity. J Tenn Med Assoc. 1986;79(2):82–4.; Parker PH, GhishanFK, Shanks D, Greene HL. Eosinophilia associated with cholestyramine. Clin Pediatr (Phila). 1981;20(10):675–6.; Weller PF. Eosinophilia and eosinophil-related disorders. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, eds. Middleton's Allergy: Principles and Practice. 6th ed. Philadelphia: Mosby; 2003. Р. 1105–26.; Falchi L, Verstovsek S. Eosinophilia in hematologic disorders. Immunol Allergy Clin North Am. 2015;35(3):439–52. https://doi.org/10.1016/j.iac.2015.04.004; Teragaki M, Kawano H, Makino R, Inoue K, Sai Y, Hosono M, et al. A case of warfarin-induced eosinophilia. Intern Med. 2012;51(12):1627–9. https://doi.org/10.2169/internalmedicine.51.7138; Pfitzenmeyer P, Meier M, Zuck P, Peiffer G, Masson P, Turcu A, et al. Piroxicam induced pulmonary infiltrates and eosinophilia. J Rheumatol. 1994;21(8):1573–7.; Bando T, Fujimura M, Noda Y, Hirose J, Ohta G, Matsuda T. Minocycline-induced pneumonitis with bilateral hilar lymphadenopathy and pleural effusion. Intern Med. 1994;33(3):177–9. https://doi.org/10.2169/internalmedicine.33.177; Umeki S. Reevaluation of eosinophilic pneumonia and its diagnostic criteria. Arch Intern Med. 1992;152(9):1913–9. https://doi.org/10.1001/archinte.1992.00400210133023; Bain GA, Flower CD. Pulmonary eosinophilia. Eur J Radiol. 1996;23(1):3–8. https://doi.org/10.1016/0720-048X(96)01029-7; Martin DM, Goldman JA, Gilliam J, Nasrallah SM. Gold-induced eosinophilic enterocolitis: response to oral cromolyn sodium. Gastroenterology. 1981;80(6):1567–70. https://doi.org/10.1016/0016-5085(81)90274-2; https://www.risksafety.ru/jour/article/view/156
-
5Academic Journal
Authors: A. S. Kazakov, T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. O. Zhuravleva, А. С. Казаков, Т. М. Букатина, Н. Ю. Вельц, М. А. Дармостукова, Е. О. Журавлева
Source: Safety and Risk of Pharmacotherapy; Том 5, № 3 (2017); 112-116 ; Безопасность и риск фармакотерапии; Том 5, № 3 (2017); 112-116 ; 2619-1164 ; 2312-7821 ; undefined
Subject Terms: artemisinin derivatives, противомалярийные препараты, производные артемизинина, malaria, antimalarial drugs
File Description: application/pdf
Relation: https://www.risksafety.ru/jour/article/view/79/80; Всемирная организация здравоохранения (WHO) [Internet]. 2017 (дата обращения 15.05.2017). Доступно на: http://www.who.int.; Kovacs SD, Rijken MJ, Stergachis A. Treating Severe Malaria in Pregnancy: A Review of the Evidence. Drug Safety 2015; 38: 165-181.; Попов АФ. Лечение малярии (лекция). Инфектология 2014; 6(1): 5-12.; Токмалаев АК. Малярия: современное состояние диагностики и лечения. Вестник РУДН 2011; 3: 82-88.; Иванова ТН, Петрова ГН, Тимошенко НИ. Маляриологическая ситуация в Москве 2000-2004 гг. Медицинская паразитология и паразитарные болезни 2005; 4: 3-7.; Лысенко АЯ, Кондрашин АВ, Ежов МН. Маляриология (2 издание). ВОЗ; 2003.; Попов АФ, Токмалаев АК, Никифоров НД. Малярия. М.: РУДН; 2004.; Кондрашин АВ. Международный конгресс по элиминации малярии. Медицинская паразитология и паразитарные болезни 2012; 3: 61-3.; Снегирева ИИ, Затолочина КЭ, Озерецковский НА, Романов БК, Миронов АН. Фармаконадзор вакцин в России, нормативно-правовое регулирование, особенности развития на современном этапе. Ведомости Научного центра экспертизы средств медицинского применения 2014; 4: 27-31.; https://www.risksafety.ru/jour/article/view/79; undefined
Availability: https://www.risksafety.ru/jour/article/view/79
-
6Dissertation/ Thesis
Subject Terms: малярия, malaria, малярія, противомалярийные препараты, протималярійні препарати
File Description: application/pdf